Oct 062020
Talent4Boards - Great Talent builds Great Boards
– NETHERLANDS, Amsterdam – Neogene Therapeutics, Inc., a pre-clinical stage biotechnology company pioneering a new class of fully personalized neo-antigen T cell therapies to treat cancer, today announced the appointment of Dr. Franz Humer, Ph.D., as Executive Chairman of the Board of Directors. A world-renowned pharmaceutical industry trailblazer, Dr. Humer ...
Neogene Therapeutics welcomes Dr. Franz Humer as Executive Chairman alongside a slate of women in VC onto Board of Directors
Sorry, the comment form is closed at this time.